Microlax (Sodium Citrate, Sorbitol (E420), Sodium Lauryl Sulfoacetate)

Sodium citrate creates an osmotic gradient that draws water into the colon, softening stool. Together with sodium lauryl sulfoacetate, which lowers surface tension, the formulation stimulates peristalsis and promotes rapid evacuation of the bowel.

The appropriate dose of Microlax is determined by the prescribing healthcare professional based on the individual’s condition, age and response. Users should follow the instructions on the product label or the guidance provided by their clinician.

Safety data for Microlax in pregnancy and lactation are limited. It should be used only if clearly needed and after consultation with a qualified healthcare provider, who can weigh potential benefits against any unknown risks.

To place an order, submit an enquiry on the Microlax product page at gnhindia.com, specifying the required quantity. GNH India supplies hospitals, pharmacies and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details and any required import documentation.

Compared with oral osmotic laxatives, Microlax provides a rapid, localized effect via rectal administration, avoiding systemic absorption. It is often preferred when quick relief is needed or when oral routes are unsuitable, whereas oral agents may be used for chronic management.

Microlax should be stored at room temperature, below 25 °C, in its original packaging to protect it from moisture and direct sunlight. Keep the container tightly closed and out of reach of children.

Microlax is administered rectally. The patient lies on their left side, inserts the pre‑filled applicator gently into the rectum, and slowly releases the contents. The patient should remain in the same position for a few minutes to allow the solution to work before attempting to evacuate.

Serious risks, though rare, include severe abdominal pain, rectal bleeding, allergic reactions such as rash or swelling, and electrolyte imbalance if used excessively. Any of these symptoms warrant immediate medical attention.

Microlax should not be used by individuals with known hypersensitivity to any of its ingredients, those with intestinal obstruction, severe inflammatory bowel disease, or acute rectal lesions. Children under the age recommended on the label should also avoid use unless directed by a clinician.